Immunomodulating properties of PD-L1 positive cancer stem cells in metastatic lymph nodes

A. Raniszewska (Warsaw, Poland), H. Vroman (Rotterdam, Netherlands), D. Dumoulin (Rotterdam, Netherlands), J. Domagala-Kulawik (Warsaw, Poland), J. Aerts (Rotterdam, Netherlands)

Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer
Session: Diagnostic procedures and biology of lung cancer
Session type: Oral Presentation
Number: 1910
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Raniszewska (Warsaw, Poland), H. Vroman (Rotterdam, Netherlands), D. Dumoulin (Rotterdam, Netherlands), J. Domagala-Kulawik (Warsaw, Poland), J. Aerts (Rotterdam, Netherlands). Immunomodulating properties of PD-L1 positive cancer stem cells in metastatic lymph nodes. 1910

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
PD-L1 expression on lung cancer stem cells in metastatic lymph nodes.
Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management
Year: 2018



Immunomodulating properties of FasL+ lung cancer cells identified in lymph nodes aspirates of NSCLC patients
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


T cell maturation profile in metastatic vs. non-metastatic lymph nodes in NSCLC patients
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodes
Source: ERJ Open Res, 3 (2) 00110-2016; 10.1183/23120541.00110-2016
Year: 2017



Immunosuppressive properties of human PD-1+ PDL-1+ dendritic cell from Lymph Nodes Aspirates of NSCLC patients.
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


An usual metastasis of squamous cell lung cancer: intra-abdominal lymph nodes
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009

Adenoviral transduction of MRP-1/CD9 and KAI-1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model
Source: Eur Respir J 2006; 28: Suppl. 50, 389s
Year: 2006

Correlation between p53 expression in bronchus biopsies from non-small cell lung cancer cases and mediastinal lymph node invasion demonstrated through mediastinoscopy
Source: Eur Respir J 2006; 28: Suppl. 50, 82s
Year: 2006

Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012


Different morphological changes in non-small cell lung cancers and their corresponding lymph node metastases after neoadjuvant therapy?
Source: Eur Respir J 2004; 24: Suppl. 48, 479s
Year: 2004

Lymph nodes frozen section in staging of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 534s
Year: 2005

Lung cancer size and thoracic lymph nodes metastatic involvement: a correlation
Source: Eur Respir J 2004; 24: Suppl. 48, 671s
Year: 2004

Lung cancer size and thoracic lymph nodes metastatic involvement: A correlation
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011

Human dendritic cells with PD-1+ CD80+ expression from lymph nodes aspirates of sarcoidosis patients.
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021


Increased T-regulatory cells in lungs and draining lymph nodes in a murine model of COPD
Source: Eur Respir J 2010; 35: 688-689
Year: 2010


Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis in resected non–small cell lung cancer
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009

Central tumor location and presence of occult lymph node metastasis in cT1N0M0 NSCLC
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019


Detection of lung cancer micrometastases in lymph nodes aspirates by flow cytometry.
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


Telomerase activity, micrometastasis and lynphonodal metastasis in resected non small cell lung cancer
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008